Literature DB >> 17521507

The role of the collagen matrix in skeletal fragility.

Deepak Vashishth1.   

Abstract

The collagen network in bone provides resistance against fracture and may be susceptible to changes with aging and disease. This review identifies the changes in quality of collagen matrix as contributors to bone fragility. With aging and in diabetes, cross-links accumulate in bone collagen as a result of nonenzymatic glycation and consequently impair matrix properties, increasing bone fragility. Cell-culture and animal studies suggest that the accumulation of cross-links induced by nonenzymatic glycation may be related to a reduction in bone turnover resulting from the altered responses of osteoblasts and osteoclasts to advanced glycation end products.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17521507     DOI： 10.1007/s11914-007-0004-2

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN： 1544-1873            Impact factor:   5.096


  47 in total

1.  Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation.

Authors:  A D McCarthy; S B Etcheverry; A M Cortizo
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

2.  Influence of nonenzymatic glycation on biomechanical properties of cortical bone.

Authors:  D Vashishth; G J Gibson; J I Khoury; M B Schaffler; J Kimura; D P Fyhrie
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

Review 3.  The role of collagen in bone strength.

Authors:  S Viguet-Carrin; P Garnero; P D Delmas
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

4.  The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade.

Authors:  Janardhan S Yerramshetty; Cora Lind; Ozan Akkus
Journal:  Bone       Date:  2006-07-21       Impact factor: 4.398

5.  Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.

Authors:  Ulrich Valcourt; Blandine Merle; Evelyne Gineyts; Stéphanie Viguet-Carrin; Pierre D Delmas; Patrick Garnero
Journal:  J Biol Chem       Date:  2006-12-01       Impact factor: 5.157

6.  Effects of non-enzymatic glycation on cancellous bone fragility.

Authors:  S Y Tang; U Zeenath; D Vashishth
Journal:  Bone       Date:  2006-12-21       Impact factor: 4.398

7.  Bone indentation recovery time correlates with bond reforming time.

Authors:  J B Thompson; J H Kindt; B Drake; H G Hansma; D E Morse; P K Hansma
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

8.  Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae.

Authors:  S Viguet-Carrin; J P Roux; M E Arlot; Z Merabet; D J Leeming; I Byrjalsen; P D Delmas; M L Bouxsein
Journal:  Bone       Date:  2006-07-10       Impact factor: 4.398

Review 9.  Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance.

Authors:  L Knott; A J Bailey
Journal:  Bone       Date:  1998-03       Impact factor: 4.398

10.  Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose.

Authors:  K Nakamura; Y Nakazawa; K Ienaga
Journal:  Biochem Biophys Res Commun       Date:  1997-03-06       Impact factor: 3.575
View more
  65 in total

1.  Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment.

Authors:  Masataka Shiraki; Tatsuhiko Kuroda; Yumiko Shiraki; Shiro Tanaka; Tsuyoshi Higuchi; Mitsuru Saito
Journal:  J Bone Miner Metab       Date:  2010-05-11       Impact factor: 2.626

2.  Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Eric Vittinghoff; Douglas C Bauer; Teresa A Hillier; Elsa S Strotmeyer; Kristine E Ensrud; Meghan G Donaldson; Jane A Cauley; Tamara B Harris; Annemarie Koster; Catherine R Womack; Lisa Palermo; Dennis M Black
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

3.  Defects in cortical microarchitecture among African-American women with type 2 diabetes.

Authors:  E W Yu; M S Putman; N Derrico; G Abrishamanian-Garcia; J S Finkelstein; M L Bouxsein
Journal:  Osteoporos Int       Date:  2014-11-15       Impact factor: 4.507

Review 4.  Methods for assessing bone quality: a review.

Authors:  Eve Donnelly
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

5.  Femoral Neck External Size but not aBMD Predicts Structural and Mass Changes for Women Transitioning Through Menopause.

Authors:  Karl J Jepsen; Andrew Kozminski; Erin Mr Bigelow; Stephen H Schlecht; Robert W Goulet; Sioban D Harlow; Jane A Cauley; Carrie Karvonen-Gutierrez
Journal:  J Bone Miner Res       Date:  2017-01-30       Impact factor: 6.741

6.  Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone.

Authors:  Parameswari Govindarajan; Thaqif Khassawna; Marian Kampschulte; Wolfgang Böcker; Britta Huerter; Lutz Dürselen; Miriam Faulenbach; Christian Heiss
Journal:  Int J Exp Pathol       Date:  2013-09-02       Impact factor: 1.925

Review 7.  Effects of bone matrix proteins on fracture and fragility in osteoporosis.

Authors:  Grażyna E Sroga; Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

8.  Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.

Authors:  Lamya Karim; Julia Moulton; Miranda Van Vliet; Kelsey Velie; Ann Robbins; Fatemeh Malekipour; Ayesha Abdeen; Douglas Ayres; Mary L Bouxsein
Journal:  Bone       Date:  2018-05-30       Impact factor: 4.398

Review 9.  Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones.

Authors:  Karl J Jepsen; Matthew J Silva; Deepak Vashishth; X Edward Guo; Marjolein C H van der Meulen
Journal:  J Bone Miner Res       Date:  2015-06       Impact factor: 6.741

10.  Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

Authors:  S Y Tang; M R Allen; R Phipps; D B Burr; D Vashishth
Journal:  Osteoporos Int       Date:  2008-10-11       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.